Phase II trial of anastrozole in women with asymptomatic müllerian cancer

This publication has 16 references indexed in Scilit:

• Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group
  Journal of Clinical Oncology, 2001
• Aromatase Inhibitors in the Treatment and Prevention of Breast Cancer
  Journal of Clinical Oncology, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex®) with intramuscular formestane in postmenopausal women with advanced breast cancer
  Annals of Oncology, 1999
• New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women
  The Netherlands Journal of Medicine, 1999
• Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma
  Cancer, 1998
• Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.
  Journal of Clinical Oncology, 1996
• Ovarian Cancer: Latest Gains Establish New Battle Fronts
  JNCI Journal of the National Cancer Institute, 1995
• Immunohistochemical studies of steroidogenic enzymes (aromatase, 17α-hydroxylase and cholesterol side-chain cleavage cytochromes P-450) in sex cord-stromal tumors of the ovary
  Human Pathology, 1989
• Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: An EORTC gynecological cancer cooperative group study
  Gynecologic Oncology, 1985